Canada markets open in 8 hours 40 minutes

FSD Pharma Inc. (HUGE.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.3000+0.0100 (+3.45%)
At close: 03:15PM EDT

FSD Pharma Inc.

55 University Ave.
Suite 1003
Toronto, ON M5J 2H7
Canada

https://www.fsdpharma.com

Sector(s)Healthcare
IndustryDrug Manufacturers - Specialty & Generic
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Zeeshan SaeedFounder, CEO, President & Executive Co-Chairman306.24kN/A1970
Mr. Anthony John DurkaczFounder & Executive Co-Chairman306.24kN/A1976
Mr. Nathan Coyle CPAChief Financial Officer245.14kN/A1981
Mr. Donal Carroll CPAChief Operating Officer310.37kN/A1977
Dr. Lakshmi P. Kotra BPHARM, Ph.D.CEO of Lucid & Director199.08kN/A1971
Ms. Maryann AdessoCorporate SecretaryN/AN/AN/A
Randell MackPresident of FSD BioSciencesN/AN/AN/A
Dr. Andrzej Chruscinski M.D., Ph.D.Vice President of Clinical & Scientific Affairs of Lucid151.73kN/AN/A
Mr. Kevin CassidyVice President of Quality-Lucid199.22kN/AN/A
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

FSD Pharma Inc., a biopharmaceutical company, researches and develops a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. The company operates through two segments, Biopharmaceutical and Strategic Investments. Its lead compound is Lucid-MS, a patented new chemical entity that is in Phase 2 clinical trial to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company is also developing a treatment for alcohol misuse for application in hospitals and other medical practices. In addition, it maintains a portfolio of strategic investments comprising loans secured by residential property. FSD Pharma Inc. is headquartered in Toronto, Canada.

Corporate Governance

FSD Pharma Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.